Payment overview · 2025
General Payments
$158.32
4 reported records · 1 companies
Healthcare provider profile · identity verified
Bulent Ozcakar
Allopathic & Osteopathic Physicians|Internal Medicine · DANBURY, CT · NPI 1174935894
Verified facts
What the public records show
CMS Open Payments records show Bulent Ozcakar received $158.32 in general payments during 2025 across 4 reported records.
Neurocrine BioSciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ingrezza.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 52 claims for Ingrezza by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $158.32 | 100.0% | 4 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $158.32 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $158.32 | 4 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 52 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
52 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Trazodone Hcl | Trazodone Hcl | 1445 | 226 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1317 | 201 |
| Eliquis | Apixaban | 1102 | 122 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1011 | 126 |
| Amlodipine Besylate | Amlodipine Besylate | 824 | 120 |
| Furosemide | Furosemide | 781 | 110 |
| Gabapentin | Gabapentin | 590 | 96 |
| Escitalopram Oxalate | Escitalopram Oxalate | 556 | 83 |
| Pantoprazole Sodium | Pantoprazole Sodium | 545 | 103 |
| Metoprolol Succinate | Metoprolol Succinate | 541 | 81 |
| Risperidone | Risperidone | 517 | 49 |
| Quetiapine Fumarate | Quetiapine Fumarate | 462 | 58 |
| Mirtazapine | Mirtazapine | 459 | 79 |
| Potassium Chloride | Potassium Chloride | 419 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 415 | 66 |
| Divalproex Sodium | Divalproex Sodium | 413 | 61 |
| Losartan Potassium | Losartan Potassium | 405 | 55 |
| Lisinopril | Lisinopril | 404 | 68 |
| Metformin Hcl | Metformin Hcl | 378 | 54 |
| Sertraline Hcl | Sertraline Hcl | 369 | 55 |
| Metoprolol Tartrate | Metoprolol Tartrate | 365 | 72 |
| Donepezil Hcl | Donepezil Hcl | 297 | 45 |
| Olanzapine | Olanzapine | 297 | 46 |
| Carvedilol | Carvedilol | 278 | 45 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 256 | 42 |
| Levetiracetam | Levetiracetam | 251 | 38 |
| Jardiance | Empagliflozin | 233 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 212 | 25 |
| Benztropine Mesylate | Benztropine Mesylate | 201 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 199 | 34 |
| Baclofen | Baclofen | 189 | 36 |
| Entresto | Sacubitril/Valsartan | 189 | 14 |
| Clozapine | Clozapine | 187 | suppressed |
| Simvastatin | Simvastatin | 183 | 29 |
| Omeprazole | Omeprazole | 178 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 176 | 26 |
| Famotidine | Famotidine | 171 | 33 |
| Finasteride | Finasteride | 170 | 27 |
| Spironolactone | Spironolactone | 167 | 32 |
| Xarelto | Rivaroxaban | 167 | 22 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 156 | 24 |
| Trulicity | Dulaglutide | 155 | 18 |
| Gemtesa | Vibegron | 135 | 12 |
| Latanoprost | Latanoprost | 126 | 27 |
| Hydralazine Hcl | Hydralazine Hcl | 125 | 23 |
| Montelukast Sodium | Montelukast Sodium | 123 | 24 |
| Aripiprazole | Aripiprazole | 116 | 18 |
| Prednisone | Prednisone | 116 | 41 |
| Alendronate Sodium | Alendronate Sodium | 113 | 15 |
| Torsemide | Torsemide | 111 | 24 |
| Memantine Hcl | Memantine Hcl | 110 | 19 |
| Ondansetron Hcl | Ondansetron Hcl | 110 | 52 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 108 | 51 |
| Citalopram Hbr | Citalopram Hydrobromide | 107 | 16 |
| Allopurinol | Allopurinol | 101 | 23 |
| Divalproex Sodium Er | Divalproex Sodium | 100 | 12 |
| Tradjenta | Linagliptin | 99 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 98 | 24 |
| Topiramate | Topiramate | 97 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 95 | 17 |
| Midodrine Hcl | Midodrine Hcl | 91 | 19 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 89 | 17 |
| Atenolol | Atenolol | 87 | 14 |
| Lactulose | Lactulose | 87 | 27 |
| Paroxetine Hcl | Paroxetine Hcl | 86 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 86 | 24 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 84 | 29 |
| Haloperidol | Haloperidol | 84 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 81 | 22 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 81 | 21 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 81 | 11 |
| Lamotrigine | Lamotrigine | 81 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 78 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 74 | 15 |
| Farxiga | Dapagliflozin Propanediol | 73 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 73 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 72 | 38 |
| Oxcarbazepine | Oxcarbazepine | 72 | suppressed |
| Januvia | Sitagliptin Phosphate | 70 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 69 | 66 |
| Austedo | Deutetrabenazine | 68 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 68 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 68 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 67 | suppressed |
| Ezetimibe | Ezetimibe | 67 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 67 | 27 |
| Albuterol Sulfate | Albuterol Sulfate | 66 | 23 |
| Bupropion Xl | Bupropion Hcl | 66 | 13 |
| Buspirone Hcl | Buspirone Hcl | 66 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 66 | 11 |
| Humalog | Insulin Lispro | 64 | 23 |
| Tramadol Hcl | Tramadol Hcl | 64 | 32 |
| Hydrochlorothiazide | Hydrochlorothiazide | 63 | 11 |
| Rexulti | Brexpiprazole | 61 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 58 | suppressed |
| Myrbetriq | Mirabegron | 56 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 55 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 54 | 41 |
| Bumetanide | Bumetanide | 54 | 13 |
| Glipizide | Glipizide | 54 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 53 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 52 | suppressed |
| Ingrezza | Valbenazine Tosylate | 52 | suppressed |
| Lidocaine | Lidocaine | 50 | 13 |
| Enulose | Lactulose | 49 | 15 |
| Breo Ellipta | Fluticasone/Vilanterol | 48 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 48 | 18 |
| Cephalexin | Cephalexin | 47 | 33 |
| Doxazosin Mesylate | Doxazosin Mesylate | 47 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 46 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 46 | 26 |
| Insulin Lispro | Insulin Lispro | 46 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 46 | 23 |
| Perphenazine | Perphenazine | 46 | suppressed |
| Digoxin | Digoxin | 44 | 11 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 42 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 42 | 24 |
| Lokelma | Sodium Zirconium Cyclosilicate | 41 | suppressed |
| Lorazepam | Lorazepam | 41 | 25 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 40 | 40 |
| Prednisolone Acetate | Prednisolone Acetate | 40 | 11 |
| Tresiba Flextouch U-100 | Insulin Degludec | 40 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 39 | 25 |
| Doxycycline Hyclate | Doxycycline Hyclate | 39 | 27 |
| Zenpep | Lipase/Protease/Amylase | 39 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 38 | 14 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 38 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 38 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 38 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 37 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 37 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 36 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 36 | suppressed |
| Nystatin | Nystatin | 36 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 36 | 12 |
| Timolol Maleate | Timolol Maleate | 36 | suppressed |
| Xifaxan | Rifaximin | 36 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 35 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 35 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 35 | 19 |
| Haloperidol Decanoate | Haloperidol Decanoate | 34 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 34 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 34 | suppressed |
| Ketoconazole | Ketoconazole | 33 | 14 |
| Amantadine | Amantadine Hcl | 32 | suppressed |
| Carbamazepine | Carbamazepine | 32 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 31 | suppressed |
| Clonazepam | Clonazepam | 30 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 30 | 20 |
| Prazosin Hcl | Prazosin Hcl | 30 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 30 | suppressed |
| Acetazolamide | Acetazolamide | 29 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 29 | suppressed |
| Linzess | Linaclotide | 29 | suppressed |
| Pregabalin | Pregabalin | 29 | suppressed |
| Vraylar | Cariprazine Hcl | 29 | suppressed |
| Hydrocortisone | Hydrocortisone | 28 | 11 |
| Azelastine Hcl | Azelastine Hcl | 27 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 27 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 27 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 26 | 13 |
| Methocarbamol | Methocarbamol | 26 | suppressed |
| Celecoxib | Celecoxib | 25 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 25 | suppressed |
| Glimepiride | Glimepiride | 25 | suppressed |
| Ibuprofen | Ibuprofen | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 25 | suppressed |
| Ramipril | Ramipril | 25 | suppressed |
| Ranolazine Er | Ranolazine | 25 | suppressed |
| Sulfasalazine | Sulfasalazine | 25 | suppressed |
| Aranesp | Darbepoetin Alfa In Polysorbat | 24 | suppressed |
| Meloxicam | Meloxicam | 24 | suppressed |
| Mupirocin | Mupirocin | 24 | 13 |
| Estradiol | Estradiol | 23 | suppressed |
| Lansoprazole | Lansoprazole | 23 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 22 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 22 | suppressed |
| Erythromycin | Erythromycin Base | 22 | 12 |
| Haloperidol Lactate | Haloperidol Lactate | 22 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 22 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 22 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 22 | suppressed |
| Fluconazole | Fluconazole | 21 | 12 |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 21 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 21 | suppressed |
| Novolog | Insulin Aspart | 21 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Dofetilide | Dofetilide | 20 | suppressed |
| Sucralfate | Sucralfate | 20 | suppressed |
| Vascepa | Icosapent Ethyl | 20 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 13 |
| Ubrelvy | Ubrogepant | 19 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 18 | suppressed |
| Ondansetron Odt | Ondansetron | 18 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 18 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 18 | suppressed |
| Alprazolam | Alprazolam | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 17 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 17 | suppressed |
| Prezcobix | Darunavir/Cobicistat | 17 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 16 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Paliperidone Er | Paliperidone | 16 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 16 | 13 |
| Trospium Chloride | Trospium Chloride | 16 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 15 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 15 | 14 |
| Irbesartan | Irbesartan | 15 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Cilostazol | Cilostazol | 14 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 14 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 14 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 14 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 14 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 14 | suppressed |
| Levemir | Insulin Detemir | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Ofloxacin | Ofloxacin | 14 | suppressed |
| Olanzapine Odt | Olanzapine | 14 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 14 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Dimethyl Fumarate | Dimethyl Fumarate | 13 | suppressed |
| Entacapone | Entacapone | 13 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Lubiprostone | Lubiprostone | 13 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 13 | 11 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Phenytoin | Phenytoin | 13 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 12 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Azithromycin | Azithromycin | 12 | 11 |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 12 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 12 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 12 | suppressed |
| Mesalamine | Mesalamine | 12 | suppressed |
| Nyamyc | Nystatin | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 12 | suppressed |
| Restasis | Cyclosporine | 12 | suppressed |
| Scopolamine | Scopolamine | 12 | suppressed |
| Ursodiol | Ursodiol | 12 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Leflunomide | Leflunomide | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Niacin Er | Niacin | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $158.32 · 4 records | Neurocrine BioSciences, Inc. | INGREZZA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ingrezza play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Neurocrine BioSciences, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error